We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.53%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.36B
AUM Growth
+$77.6M
Cap. Flow
+$46.1M
Cap. Flow %
3.39%
Top 10 Hldgs %
13.88%
Holding
1,633
New
514
Increased
325
Reduced
386
Closed
373

Top Buys

Rank Stock Value
1
NICE icon
Nice
NICE
+$14.2M
2
DOMO icon
Domo
DOMO
+$12.7M
3
NFLX icon
Netflix
NFLX
+$12.4M
4
EA
Electronic Arts
EA
+$12.3M
5
DAY
Dayforce
DAY
+$11.5M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$17.1M
2
COOP
Mr. Cooper
COOP
+$13.5M
3
K
Kellanova
K
+$11.9M
4
LITE icon
Lumentum
LITE
+$9.69M
5
IBIT icon
iShares Bitcoin Trust
IBIT
+$9.44M

Sector Composition

Rank Sector Weight
1 Technology 23.27%
2 Healthcare 13.54%
3 Communication Services 10.55%
4 Consumer Discretionary 9.61%
5 Industrials 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMAL icon
1276
Amalgamated Financial
AMAL
$1.48B
– –
-7,550
Closed -$205K
AMBP icon
1277
Ardagh Metal Packaging
AMBP
$2.97B
– –
-50,000
Closed -$200K
AMPX icon
1278
Amprius Technologies
AMPX
$1.73B
– –
-14,018
Closed -$147K
GOLD
1279
Gold.com Inc
GOLD
$1.26B
– –
-11,295
Closed -$292K
AMRX icon
1280
Amneal Pharmaceuticals
AMRX
$5.71B
– –
-13,801
Closed -$138K
ANDE icon
1281
Andersons Inc
ANDE
$2.23B
– –
-5,213
Closed -$208K
APEI icon
1282
American Public Education
APEI
$869M
– –
-11,200
Closed -$442K
APGE icon
1283
Apogee Therapeutics
APGE
$10.2B
– –
-26,241
Closed -$1.04M
APPN icon
1284
Appian
APPN
$2.55B
– –
-10,168
Closed -$311K
ARRY icon
1285
Array Technologies
ARRY
$819M
– –
-41,759
Closed -$340K
ASLE icon
1286
AerSale
ASLE
$274M
– –
-24,700
Closed -$202K
ASPN icon
1287
Aspen Aerogels
ASPN
$521M
– –
-10,109
Closed -$70.4K
ASR icon
1288
Grupo Aeroportuario del Sureste
ASR
$8.24B
– –
-6,987
Closed -$2.26M
ASTL icon
1289
Algoma Steel
ASTL
$468M
– –
-26,758
Closed -$95.1K
ATAI icon
1290
AtaiBeckley Inc
ATAI
$2.68B
– –
-11,291
Closed -$59.7K
ATEC icon
1291
Alphatec Holdings
ATEC
$1.47B
– –
-20,338
Closed -$296K
ATI icon
1292
ATI
ATI
$31.1B
– –
-2,689
Closed -$219K
ATRO icon
1293
Astronics
ATRO
$3.72B
– –
-12,499
Closed -$475K
AU icon
1294
AngloGold Ashanti
AU
$49.2B
– –
-3,021
Closed -$212K
AVDX
1295
DELISTED
AvidXchange
AVDX
– –
-114,226
Closed -$1.14M
AVPT icon
1296
AvePoint
AVPT
$2.75B
– –
-12,470
Closed -$187K
AVTX icon
1297
Avalo Therapeutics
AVTX
$1.06B
– –
-24,628
Closed -$313K
AWI icon
1298
Armstrong World Industries
AWI
$7.75B
– –
-1,229
Closed -$241K
AXS icon
1299
AXIS Capital
AXS
$7.43B
– –
-3,200
Closed -$307K
BAH icon
1300
Booz Allen Hamilton
BAH
$9.37B
– –
-3,571
Closed -$357K
50 51
52
53 54

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Prelude Capital Management held 1,633 positions worth $1.36B, up 6.1% from $1.28B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management deployed $46.1M of net new capital in Q4 2025, opening 514 new positions and adding to 325 existing holdings. Its largest new stake was Nice: 117,600 shares worth $13.3M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Lumentum, an estimated $9.69M trimmed.

  • Prelude Capital Management's largest Q4 2025 buy was Nice: 117,600 shares worth $13.3M.
  • Prelude Capital Management added most to Domo in Q4 2025, an estimated $12.7M increase.
  • Prelude Capital Management's biggest Q4 2025 reduction was Lumentum, cutting an estimated $9.69M.
  • Prelude Capital Management fully exited Verona Pharma in Q4 2025, selling an estimated $17.1M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $1.36B portfolio in Q4 2025.
  • Prelude Capital Management opened 514 new positions and closed 373 in Q4 2025.
  • Prelude Capital Management's portfolio value rose 6.1% quarter-over-quarter to $1.36B.

Based on Prelude Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.